Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

15.2K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
No description available
4.5K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.5K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

18.9K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.9K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

8.6K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.6K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

553
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
553

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

METTL3-mediated m6A modification of PAK6 drives cervical cancer progression through activating MAPK14.

International journal of biological macromolecules·2025
Same author

The role of USP7-YY1 interaction in promoting colorectal cancer growth and metastasis.

Cell death & disease·2024
Same author

Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo.

Cell death & disease·2024
Same author

Crosstalk between m6A modification and alternative splicing during cancer progression.

Clinical and translational medicine·2023
Same author

Sorafenib induces ferroptosis by promoting TRIM54-mediated FSP1 ubiquitination and degradation in hepatocellular carcinoma.

Hepatology communications·2023
Same author

HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5.

Pharmacological research·2023

Related Experiment Video

Updated: Feb 10, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

946

An oncogenic kinase: putting PAK5 forward.

Yi-Yang Wen1, Jun-Nian Zheng, Dong-Sheng Pei

  • 1Jiangsu Key Laboratory of Biological Cancer Therapy, Xuzhou Medical College , 84 West Huai-hai Road, Xuzhou, Jiangsu , China +86 0516 85582513 ; dspei@xzmc.edu.cn ; jnzheng@xzmc.edu.cn.

Expert Opinion on Therapeutic Targets
|May 30, 2014
PubMed
Summary

p21-activated kinase 5 (PAK5) is overexpressed in many tumors, contributing to proliferation and anti-apoptosis. Understanding PAK5

Keywords:
antiapoptosisinvasionmetastasisp21-activated kinase 5proliferation

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.7K
Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

19.4K

Related Experiment Videos

Last Updated: Feb 10, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

946
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.7K
Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

19.4K

Area of Science:

  • Oncology
  • Molecular Biology
  • Signal Transduction

Background:

  • p21-activated kinase 5 (PAK5) overexpression is implicated in various cancers.
  • PAK5 plays a role in cellular processes crucial for tumor growth, including proliferation, cytoskeleton regulation, and anti-apoptosis.

Purpose of the Study:

  • To review the current understanding of PAK5's function as an oncogenic kinase.
  • To elucidate the mechanisms and pathways by which PAK5 regulates tumor cellular processes.

Main Methods:

  • This review synthesizes existing research on PAK5.
  • It discusses molecular pathways involved in PAK5-mediated cytoskeleton regulation, anti-apoptosis, and proliferation.

Main Results:

  • PAK5, a serine/threonine kinase, shares domains with other PAKs but has unique regions.
  • Its overexpression in tumors is linked to enhanced proliferation, altered cytoskeleton, and resistance to apoptosis.
  • PAK5 exhibits regulatory mechanisms independent of Rho GTPases.

Conclusions:

  • PAK5 acts as a distinct signaling molecule in tumor progression.
  • Its unique properties suggest potential as a therapeutic target.
  • Further research into PAK5's independent regulatory mechanisms is warranted for novel cancer treatments.